LUMEXA IMAGING HOLDINGS INC (LMRI) — insider trading
Health Care · NASDAQ
LUMEXA IMAGING HOLDINGS INC (LMRI) has 12 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases among the most recent 12 (latest 2026-06-10).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-10 | BRODNAX BRETT | Director | Grant / award / vesting | 19,358 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Cooper Henry Lee | Director | Grant / award / vesting | 19,358 | $0.00 | $0 | Form 4 |
| 2026-06-10 | EISENBERG GLENN A | Director | Grant / award / vesting | 19,358 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Joseph Molly | Director | Grant / award / vesting | 19,358 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Karlin Bridget E | Director | Grant / award / vesting | 19,358 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Lungren Matthew | Director | Grant / award / vesting | 19,358 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Mittl Robert Louis Jr. | Director | Grant / award / vesting | 19,358 | $0.00 | $0 | Form 4 |
| 2026-05-19 | BRODNAX BRETT | Director | Open-market purchase | 35,000 | $7.25 | $253.8K | Form 4 |
| 2026-05-14 | Cooper Henry Lee | Director | Open-market purchase | 30,000 | $7.44 | $223.1K | Form 4 |
| 2026-02-25 | Walker James Edward Jr. | Officer (Principal Accounting Officer) | Grant / award / vesting | 12,414 | $0.00 | $0 | Form 4 |
| 2025-12-12 | Martin James Anthony | Officer (Chief Financial Officer) | Grant / award / vesting | 27,027 | $0.00 | $0 | Form 4 |
| 2025-12-12 | Martin James Anthony | Officer (Chief Financial Officer) | Grant / award / vesting | 27,027 | $0.00 | $0 | Form 4 |
Ask the chat about LMRI's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: LUMEXA IMAGING HOLDINGS INC (LMRI).
Last updated 2026-06-10 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.